- Home
- IKT vs FRD Comparison
IKT vs FRD Comparison
Compare IKT & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- FRD
- Stock Information
- Founded
- IKT 2008
- FRD 1965
- Country
- IKT United States
- FRD United States
- Employees
- IKT N/A
- FRD N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- FRD Steel/Iron Ore
- Sector
- IKT Health Care
- FRD Industrials
- Exchange
- IKT Nasdaq
- FRD Nasdaq
- Market Cap
- IKT 140.5M
- FRD 114.4M
- IPO Year
- IKT 2020
- FRD N/A
- Fundamental
- Price
- IKT $1.71
- FRD $17.60
- Analyst Decision
- IKT Buy
- FRD
- Analyst Count
- IKT 2
- FRD 0
- Target Price
- IKT $8.00
- FRD N/A
- AVG Volume (30 Days)
- IKT 117.1K
- FRD 22.9K
- Earning Date
- IKT 08-26-2025
- FRD 08-07-2025
- Dividend Yield
- IKT N/A
- FRD 0.91%
- EPS Growth
- IKT N/A
- FRD N/A
- EPS
- IKT N/A
- FRD 1.21
- Revenue
- IKT N/A
- FRD $464,826,000.00
- Revenue This Year
- IKT N/A
- FRD N/A
- Revenue Next Year
- IKT N/A
- FRD N/A
- P/E Ratio
- IKT N/A
- FRD $14.45
- Revenue Growth
- IKT N/A
- FRD N/A
- 52 Week Low
- IKT $1.12
- FRD $12.24
- 52 Week High
- IKT $4.20
- FRD $18.48
- Technical
- Relative Strength Index (RSI)
- IKT 49.23
- FRD 69.18
- Support Level
- IKT $1.42
- FRD $14.51
- Resistance Level
- IKT $1.83
- FRD $17.78
- Average True Range (ATR)
- IKT 0.15
- FRD 0.63
- MACD
- IKT 0.00
- FRD 0.30
- Stochastic Oscillator
- IKT 62.11
- FRD 94.50
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.